Apollo Hospitals Enterprise Share Price Target 2026: Analyst Forecast, Bull & Bear Case

Thu Apr 09 2026

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) is trading at Rs 6,200 as of April 2026, against a 52-week high of undefined and a 52-week low of undefined. The analyst consensus 12-month Apollo Hospitals Enterprise share price target stands at Rs 7,200-8,000 — implying meaningful upside from current levels. This article covers the current share price, key catalysts, risks, technical support levels, institutional positioning, and a structured breakdown of the short-term, 12-month, and long-term share price targets.

Table of Contents

Current Price Overview

Metric	Value
Current Market Price (CMP)	Rs 6,200
52-Week High	undefined
52-Week Low	undefined
Market Cap	Rs 89,000 Cr
P/E Ratio	82x
12M Analyst Target	Rs 7,200-8,000
Bull Case	Rs 9,500
Bear Case	Rs 4,500

About Apollo Hospitals Enterprise

Click Here – Get Free Investment Predictions

Apollo Hospitals Enterprise (NSE: APOLLOHOSP) is a leading listed company in the Healthcare sector with a market capitalisation of Rs 89,000 Cr. The company operates across its core business segments and is well-positioned for the Indian economic growth cycle.

Key Catalysts Driving Apollo Hospitals Enterprise Share Price

1. New Hospital Capacity — ARPOB Improvement

2. Apollo Hospitals is adding 2,500+ beds across Chennai, Hyderabad, Kolkata, and NCR by FY27. Revenue per occupied bed (ARPOB) is growing at 10-12% as case mix shifts toward complex procedures (oncology, cardiac, neuro).

3. Apollo 24/7 — Omnichannel Healthcare Platform

4. Apollo’s digital health platform Apollo 24/7 has 50 million+ registered users and is growing at 40%+. Monetisation through online pharmacy, teleconsultation, and home diagnostics is diversifying revenue beyond hospital beds.

5. Medical Tourism — International Patient Revenue

6. Apollo is India’s largest medical tourism destination. International patients — particularly from Africa, Middle East, and Southeast Asia — pay 3-5x the ARPOB of domestic patients. Medical tourism recovery post-COVID is now exceeding pre-2019 volumes.

7. Apollo Health and Lifestyle — Diagnostic Clinics

8. Apollo Health and Lifestyle operates 200+ clinics for primary care, dental, diagnostics, and women’s health — extending the Apollo ecosystem beyond tertiary hospitals.

Key Risks to Apollo Hospitals Enterprise Share Price

New hospital commissioning timeline delays:

ARPOB growth moderating as competition increases in Tier-1 cities:

Apollo 24/7 profitability taking longer than expected:

Government price capping on medical devices and procedures:

The 26% US reciprocal tariff on Indian goods — announced April 2, 2026 — has created a macro overhang affecting all Indian equities through FII outflows and earnings estimate revisions. Resolution of tariff uncertainty would be a meaningful positive catalyst for re-rating.

Technical Analysis and Support Levels

Apollo Hospitals Enterprise is trading at Rs 6,200 vs. a 52-week range of undefined to undefined. Key technical support is at Rs 5,800-6,600. The 200-day moving average provides medium-term guidance for trend direction.

Download the Univest iOS App or Univest Android App to track Apollo Hospitals Enterprise’s live price and get daily research insights.

Latest Quarterly Financial Performance

Key Metric	Latest Quarter	Year-Ago Quarter	YoY Change
Revenue	Rs 5,548 Cr	Rs 4,889 Cr	+13.5%
Net Profit	Rs 375 Cr	Rs 288 Cr	+30.2%
EBITDA Margin	13.2%	12.4%	+80 bps
Occupancy	65.2%	62.8%	+240 bps

Track Apollo Hospitals Enterprise’s live financials on Univest Screener

Institutional Positioning — FII, DII, Promoter

Promoter holds 28.9%. FII holding is 22.4% and DII holds 16.8%. Institutional holding trends are a critical leading indicator for price direction. Rising FII holding typically precedes price recovery; declining FII signals ongoing caution. Track institutional flow changes on Univest Screener.

Apollo Hospitals Enterprise Share Price Target 2026

Subscribe to Univest Pro for Premium Stock Research and F&O Setups

Short-Term Target (3–6 Months)

Short-term support and trading range: Rs 5,800-6,600. In the near term, the stock is likely to remain in this band pending clarity on Q4 FY26 results and FY27 guidance. Any macro positive from India-US tariff negotiations would accelerate a move toward the upper end of this range.

12-Month Analyst Target

The 12-month analyst consensus for Apollo Hospitals Enterprise is Rs 7,200-8,000. The bear case — if FY27 guidance disappoints or macro headwinds intensify — is Rs 4,500. The bull case — on full earnings delivery and macro recovery — is Rs 9,500. These are analyst estimates based on publicly available data and may differ materially from actual price performance.

Long-Term Target (2027–2028)

For 2027-2028, analysts project Apollo Hospitals Enterprise toward the Rs 10,000-12,000 range — assuming FY27 guidance delivery and normalisation of macro headwinds. Track live targets on Univest Screener.

Conclusion

The Apollo Hospitals Enterprise share price target for 2026 is Rs 7,200-8,000 based on analyst consensus. The bear case is Rs 4,500 and the bull case is Rs 9,500. At Rs 6,200, Apollo Hospitals Enterprise is trading at 82x P/E with market cap of Rs 89,000 Cr. Whether this is a buy depends on your risk tolerance, investment horizon, and portfolio context. For more share price target analysis, visit

Univest Blogs

Disclaimer: This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.

FAQs

Q1. What is Apollo Hospitals Enterprise share price target for 2026?

The 12-month analyst consensus is Rs 7,200-8,000. Bull case: Rs 9,500. Bear case: Rs 4,500.

Q2. Is Apollo Hospitals Enterprise a good buy at Rs 6,200?

At 82x P/E and Rs 6,200, Apollo Hospitals Enterprise offers potential recovery to Rs 7,200-8,000 over 12 months. Consult a SEBI-registered financial advisor before investing.

Q3. What are the key risks for Apollo Hospitals Enterprise?

Key risks include macro headwinds from US tariffs, sector-specific challenges, and any guidance miss in Q4 FY26 results. Monitor institutional holding trends on Univest Screener.

Q4. What is Apollo Hospitals Enterprise long-term share price target?

Long-term target for FY28 is Rs 10,000-12,000, contingent on sustained earnings delivery and macro recovery.